Terms: = Thyroid cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468
17 results:
1. The clinical efficacy of Apatinib plus Ba Zhen granules in the treatment of advanced unresectable differentiated thyroid cancer and their influence on immune factors.
Bai Y; Jin J; Liu Y; Zhang B; Li J
Pak J Pharm Sci; 2023 May; 36(3(Special)):935-939. PubMed ID: 37587701
[TBL] [Abstract] [Full Text] [Related]
2. The Predicting Role of Serum TSGF and sil-2R for the Lymph Node Metastasis of Papillary thyroid Carcinoma.
Xu X; Wang W; Sun T; Tian B; Du L; Jing J
Dis Markers; 2022; 2022():3730679. PubMed ID: 36092957
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and validation of a LC-MS/MS method for the determination of anlotinib in human plasma: Application to therapeutic drug monitoring.
Yu M; Liang Z; Xiong L; Liu F; Cheng L; Jia C; Qi X; Sun F
Biomed Chromatogr; 2022 Dec; 36(12):e5501. PubMed ID: 36082703
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing thyroid cancer.
Li N; Zhang J; Meng X; Yao W
J Healthc Eng; 2022; 2022():7851436. PubMed ID: 35392142
[TBL] [Abstract] [Full Text] [Related]
5. Effects of Regional and General Anesthesia on the Therapeutic Outcome of Benign thyroid Nodules Treated with High Intensity Focused Ultrasound (HIFU).
Vorländer C; Fischer A; Korkusuz H
World J Surg; 2022 May; 46(5):1076-1081. PubMed ID: 35072745
[TBL] [Abstract] [Full Text] [Related]
6. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G
Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674
[TBL] [Abstract] [Full Text] [Related]
7. Direct infusion electrospray ionization-ion mobility-mass spectrometry for comparative profiling of fatty acids based on stable isotope labeling.
Leng J; Guan Q; Sun T; Wang H; Cui J; Liu Q; Zhang Z; Zhang M; Guo Y
Anal Chim Acta; 2015 Aug; 887():148-154. PubMed ID: 26320796
[TBL] [Abstract] [Full Text] [Related]
8. [A case of angioimmunoblastic T-cell lymphoma arising in the cervical region].
Hiraga Y; Kou J; Shimomura S
Nihon Jibiinkoka Gakkai Kaiho; 2013 Oct; 116(10):1114-9. PubMed ID: 24313062
[TBL] [Abstract] [Full Text] [Related]
9. [Myeloid-derived suppressor cells in cancer patients].
Gonda K; Shibata M; Nakamura I; Kenjo A; Ohtake T; Yasuda M; Suzuki S; Suzuki H; Watanabe T; Fujimori K; Gotoh M; Takenoshita S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1797-9. PubMed ID: 23267890
[TBL] [Abstract] [Full Text] [Related]
10. Problems of primary T-cell lymphoma of the thyroid gland--a case report.
Yokoyama J; Ito S; Ohba S; Fujimaki M; Sato E; Komatsu N; Ikeda K; Hanaguri M
World J Surg Oncol; 2012 Apr; 10():58. PubMed ID: 22515161
[TBL] [Abstract] [Full Text] [Related]
11. Diagnosis of a previously unidentified primary site in patients with spinal metastasis: diagnostic usefulness of laboratory analysis, CT scanning and CT-guided biopsy.
Iizuka Y; Iizuka H; Tsutsumi S; Nakagawa Y; Nakajima T; Sorimachi Y; Ara T; Nishinome M; Seki T; Takagishi K
Eur Spine J; 2009 Oct; 18(10):1431-5. PubMed ID: 19533181
[TBL] [Abstract] [Full Text] [Related]
12. Is dermolipectomy effective in improving insulin action and lowering inflammatory markers in obese women?
Rizzo MR; Paolisso G; Grella R; Barbieri M; Grella E; Ragno E; Grella R; Nicoletti G; D'Andrea F
Clin Endocrinol (Oxf); 2005 Sep; 63(3):253-8. PubMed ID: 16117810
[TBL] [Abstract] [Full Text] [Related]
13. The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal.
Botella-Carretero JI; Prados A; Manzano L; Montero MT; Escribano L; Sancho J; Escobar-Morreale HF
Eur J Endocrinol; 2005 Aug; 153(2):223-30. PubMed ID: 16061828
[TBL] [Abstract] [Full Text] [Related]
14. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sil-2R) concentrations in peripheral blood as markers of pituitary tumours.
Komorowski J; Jankewicz J; Stepień H
Cytobios; 2000; 101(398):151-9. PubMed ID: 10755214
[TBL] [Abstract] [Full Text] [Related]
15. Low-dose IL-2 treatment: activation of discrete T- and NK-cell sub-populations in vivo.
Farace F; Angevin E; Dietrich PY; Leboullaire C; Vanderplancke J; Escudier B; Triebel F
Int J Cancer; 1995 Sep; 62(5):523-8. PubMed ID: 7665221
[TBL] [Abstract] [Full Text] [Related]
16. Serum soluble interleukin 2 (IL-2) receptor (sil-2R) in differentiated thyroid carcinoma.
Mariotti S; Barbesino G; Caturegli P; Marinò M; Manetti L; Fugazzola L; Pacini F; Pinchera A
J Endocrinol Invest; 1994 Dec; 17(11):861-7. PubMed ID: 7745234
[TBL] [Abstract] [Full Text] [Related]
17. Circulating soluble interleukin 2 receptor concentration is increased in both immunogenic and nonimmunogenic hyperthyroidism.
Mariotti S; Caturegli P; Barbesino G; Del Prete GF; Chiovato L; Pinchera A
J Endocrinol Invest; 1991 Oct; 14(9):777-81. PubMed ID: 1761814
[TBL] [Abstract] [Full Text] [Related]
